Bioanalytical Systems (BASI) Posts Q2 Loss of 27c/Share
Tweet
Share
E-mailGet Alerts BASI Hot Sheet
Price: $16.44 --0%
Financial Fact:
Cost of product revenue: 697K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenue: 697K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bioanalytical Systems (NASDAQ: BASI) reported Q2 EPS of ($0.27), $0.34 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $6.97 million versus the consensus estimate of $8.88 million.
For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.
For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
- UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
